Alain Couvineau mainly investigates Receptor, Biochemistry, Vasoactive intestinal peptide, Internal medicine and Endocrinology. His Receptor research is multidisciplinary, incorporating elements of Molecular biology and Mutant. His research investigates the connection between Biochemistry and topics such as Cell biology that intersect with issues in Golgi apparatus and 5-HT5A receptor.
In Vasoactive intestinal peptide, Alain Couvineau works on issues like Mutagenesis, which are connected to N-linked glycosylation, Asparagine, Vpac1 receptor and Site-directed mutagenesis. His work on Osteodystrophy as part of general Internal medicine study is frequently linked to Hormone metabolism, bridging the gap between disciplines. His biological study spans a wide range of topics, including Germline mutation, Peptide YY, Protein kinase A and Dissociation constant.
Receptor, Biochemistry, Vasoactive intestinal peptide, Molecular biology and G protein-coupled receptor are his primary areas of study. His Receptor research incorporates themes from Endocrinology, Binding site and Cell biology. His studies examine the connections between Endocrinology and genetics, as well as such issues in Orexin, with regards to Apoptosis.
His studies deal with areas such as Adenylyl cyclase, Ectodomain and Peptide hormone as well as Vasoactive intestinal peptide. His Molecular biology study also includes
His scientific interests lie mostly in Inflammation, Receptor, Internal medicine, Immunology and Immune system. His Inflammation research is multidisciplinary, relying on both Cancer, Multiple sclerosis and Colitis. His Receptor study is associated with Biochemistry.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology. His work carried out in the field of Endocrinology brings together such families of science as Neuropeptide and Orexin receptor. Alain Couvineau interconnects Peripheral blood mononuclear cell and Autocrine signalling in the investigation of issues within Immunology.
His primary scientific interests are in Receptor, Inflammation, Immune system, Energy homeostasis and NADPH oxidase. His Receptor research entails a greater understanding of Internal medicine. His Inflammation study incorporates themes from Interferon, Innate immune system and Peripheral blood mononuclear cell.
Alain Couvineau has researched Immune system in several fields, including Multiple sclerosis, Neuroscience and Autocrine signalling. His research integrates issues of Endocrinology, Central nervous system, Melanocortin, Neuroprotection and Disease in his study of Energy homeostasis. His research investigates the link between NADPH oxidase and topics such as Protein kinase A that cross with problems in Signal transduction and Vasoactive intestinal peptide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Arthur Christopoulos;George Christopoulos;Maria Morfis;Madhara Udawela.
Journal of Biological Chemistry (2003)
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
A S Jobert;P Zhang;A Couvineau;J Bonaventure.
Journal of Clinical Investigation (1998)
Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology
Marc Laburthe;Alain Couvineau;Var Tan.
VPAC Receptors for VIP and PACAP
M. Laburthe;A. Couvineau;J.-C. Marie.
Receptors & Channels (2002)
Receptors for VIP, PACAP, Secretin, GRF, Glucagon, GLP‐1, and Other Members of Their New Family of G Protein‐Linked Receptors: Structure‐Function Relationship with Special Reference to the Human VIP‐1 Receptora
Marc Laburthe;Alain Couvineau;Pascale Gaudin;Jean-José Maoret.
Annals of the New York Academy of Sciences (2006)
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.
M Laburthe;A Couvineau.
Regulatory Peptides (2002)
Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.
A. Couvineau;C. Rouyerfessard;D. Darmoul;J.J. Maoret.
Biochemical and Biophysical Research Communications (1994)
Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide
Marc Laburthe;Bernard Chenut;Christiane Rouyer-Fessard;Kazuhiko Tatemoto.
A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
Ping Zhang;Anne-Sixtine Jobert;Alain Couvineau;Carline Silve.
The Journal of Clinical Endocrinology and Metabolism (1998)
Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
Pascal Nicole;Laurence Lins;Christiane Rouyer-Fessard;Cyrille Drouot.
Journal of Biological Chemistry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: